메뉴 건너뛰기




Volumn 62, Issue 1, 2012, Pages

Reply to Sergey Tadtayev, Thomas A. McNicholas, and Gregory B. Boustead's letter to the editor re: Giorgio Guazzoni, Massimo Lazzeri, Luciano Nava, et al. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer. Eur Urol 2012;61:455-66

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ISOPROTEIN; PROSTATE SPECIFIC ANTIGEN;

EID: 84861633882     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.04.029     Document Type: Letter
Times cited : (6)

References (13)
  • 1
    • 84856374086 scopus 로고    scopus 로고
    • Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer
    • G. Guazzoni, M. Lazzeri, and L. Nava Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer Eur Urol 61 2012 455 466
    • (2012) Eur Urol , vol.61 , pp. 455-466
    • Guazzoni, G.1    Lazzeri, M.2    Nava, L.3
  • 2
    • 83555162514 scopus 로고    scopus 로고
    • Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men
    • T. Rhodes, D.J. Jacobson, and M.E. McGree Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men J Urol 187 2012 92 96
    • (2012) J Urol , vol.187 , pp. 92-96
    • Rhodes, T.1    Jacobson, D.J.2    McGree, M.E.3
  • 3
    • 84857863787 scopus 로고    scopus 로고
    • Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men
    • T. Rhodes, D.J. Jacobson, and M.E. McGree Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men Urology 79 2012 655 661
    • (2012) Urology , vol.79 , pp. 655-661
    • Rhodes, T.1    Jacobson, D.J.2    McGree, M.E.3
  • 4
    • 0347927256 scopus 로고    scopus 로고
    • Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment
    • L. Bruun, T. Bjork, H. Lilja, C. Becker, O. Gustafsson, and A. Christensson Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment Nephrol Dial Transplant 18 2003 598 603
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 598-603
    • Bruun, L.1    Bjork, T.2    Lilja, H.3    Becker, C.4    Gustafsson, O.5    Christensson, A.6
  • 6
    • 78149360620 scopus 로고    scopus 로고
    • Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen
    • D.A. Joseph, T. Thompson, M. Saraiya, and D.M. Werny Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen Urology 76 2010 1042 1046
    • (2010) Urology , vol.76 , pp. 1042-1046
    • Joseph, D.A.1    Thompson, T.2    Saraiya, M.3    Werny, D.M.4
  • 7
    • 26644441213 scopus 로고    scopus 로고
    • Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden
    • L. Bruun, C. Becker, J. Hugosson, H. Lilja, and A. Christensson Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden Prostate 65 2005 216 221
    • (2005) Prostate , vol.65 , pp. 216-221
    • Bruun, L.1    Becker, C.2    Hugosson, J.3    Lilja, H.4    Christensson, A.5
  • 8
    • 79956369507 scopus 로고    scopus 로고
    • Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer
    • A. Christensson, L. Bruun, and T. Bjork Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer BJU Int 107 2011 1769 1774
    • (2011) BJU Int , vol.107 , pp. 1769-1774
    • Christensson, A.1    Bruun, L.2    Bjork, T.3
  • 10
    • 34249052873 scopus 로고    scopus 로고
    • Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) - Section Rotterdam: A comparison of two rounds of screening
    • R. Postma, F.H. Schröder, and G.J.L.H. van Leenders Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC) - Section Rotterdam: a comparison of two rounds of screening Eur Urol 52 2007 89 97
    • (2007) Eur Urol , vol.52 , pp. 89-97
    • Postma, R.1    Schröder, F.H.2    Van Leenders, G.J.L.H.3
  • 11
    • 79953777963 scopus 로고    scopus 로고
    • A Multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range
    • W.J. Catalona, A.W. Partin, and M.G. Sanda A Multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range J Urol 185 2011 1650 1655
    • (2011) J Urol , vol.185 , pp. 1650-1655
    • Catalona, W.J.1    Partin, A.W.2    Sanda, M.G.3
  • 12
    • 79959554692 scopus 로고    scopus 로고
    • Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: Results of a prospective study in a clinical setting
    • G. Guazzoni, L. Nava, and M. Lazzeri Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting Eur Urol 60 2011 214 222
    • (2011) Eur Urol , vol.60 , pp. 214-222
    • Guazzoni, G.1    Nava, L.2    Lazzeri, M.3
  • 13
    • 77951621115 scopus 로고    scopus 로고
    • Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection
    • F.H. Jansen, R.H.N. van Schaik, and J. Kurstjens Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection Eur Urol 57 2010 921 927
    • (2010) Eur Urol , vol.57 , pp. 921-927
    • Jansen, F.H.1    Van Schaik, R.H.N.2    Kurstjens, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.